Literature DB >> 17450129

Quantitative proteomic assessment of very early cellular signaling events.

Joern Dengjel1, Vyacheslav Akimov, Jesper V Olsen, Jakob Bunkenborg, Matthias Mann, Blagoy Blagoev, Jens S Andersen.   

Abstract

Technical limitations have prevented proteomic analyses of events occurring less than 30 s after signal initiation. We developed an automated, continuous quench-flow system allowing quantitative proteomic assessment of very early cellular signaling events (qPACE) with a time resolution of 1 s. Using this technique, we determined that autophosphorylation of the epidermal growth factor receptor occurs within 1 s after ligand stimulation and is followed rapidly by phosphorylation of the downstream signaling intermediates Src homologous and collagen-like protein and phospholipase C gamma 1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17450129     DOI: 10.1038/nbt1301

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  28 in total

Review 1.  The coming of age of phosphoproteomics--from large data sets to inference of protein functions.

Authors:  Philippe P Roux; Pierre Thibault
Journal:  Mol Cell Proteomics       Date:  2013-09-13       Impact factor: 5.911

Review 2.  Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling.

Authors:  Hsueh-Liang Fu; Rajeshwari R Valiathan; Richard Arkwright; Anjum Sohail; Cosmin Mihai; Malika Kumarasiri; Kiran V Mahasenan; Shahriar Mobashery; Paul Huang; Gunjan Agarwal; Rafael Fridman
Journal:  J Biol Chem       Date:  2013-01-18       Impact factor: 5.157

3.  Early signaling dynamics of the epidermal growth factor receptor.

Authors:  Raven J Reddy; Aaron S Gajadhar; Eric J Swenson; Daniel A Rothenberg; Timothy G Curran; Forest M White
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

4.  Global phosphoproteomics reveals crosstalk between Bcr-Abl and negative feedback mechanisms controlling Src signaling.

Authors:  Liudmilla Rubbi; Björn Titz; Lauren Brown; Erica Galvan; Evangelia Komisopoulou; Sharon S Chen; Tracey Low; Martik Tahmasian; Brian Skaggs; Markus Müschen; Matteo Pellegrini; Thomas G Graeber
Journal:  Sci Signal       Date:  2011-03-29       Impact factor: 8.192

5.  Integrated phosphoproteomics analysis of a signaling network governing nutrient response and peroxisome induction.

Authors:  Ramsey A Saleem; Richard S Rogers; Alexander V Ratushny; David J Dilworth; Paul T Shannon; David Shteynberg; Yakun Wan; Robert L Moritz; Alexey I Nesvizhskii; Richard A Rachubinski; John D Aitchison
Journal:  Mol Cell Proteomics       Date:  2010-04-15       Impact factor: 5.911

6.  Phosphoproteomic studies of receptor tyrosine kinases: future perspectives.

Authors:  Paul H Huang
Journal:  Mol Biosyst       Date:  2011-12-02

7.  Different Epidermal Growth Factor Receptor (EGFR) Agonists Produce Unique Signatures for the Recruitment of Downstream Signaling Proteins.

Authors:  Tom Ronan; Jennifer L Macdonald-Obermann; Lorel Huelsmann; Nicholas J Bessman; Kristen M Naegle; Linda J Pike
Journal:  J Biol Chem       Date:  2016-01-19       Impact factor: 5.157

8.  The impact of peptide abundance and dynamic range on stable-isotope-based quantitative proteomic analyses.

Authors:  Corey E Bakalarski; Joshua E Elias; Judit Villén; Wilhelm Haas; Scott A Gerber; Patrick A Everley; Steven P Gygi
Journal:  J Proteome Res       Date:  2008-09-18       Impact factor: 4.466

Review 9.  Quantitative phosphoproteomic analysis of signaling network dynamics.

Authors:  Forest M White
Journal:  Curr Opin Biotechnol       Date:  2008-07-24       Impact factor: 9.740

10.  Epidermal growth factor receptor phosphorylation sites Ser991 and Tyr998 are implicated in the regulation of receptor endocytosis and phosphorylations at Ser1039 and Thr1041.

Authors:  Jiefei Tong; Paul Taylor; Scott M Peterman; Amol Prakash; Michael F Moran
Journal:  Mol Cell Proteomics       Date:  2009-06-15       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.